|
Tomazic, B B (2001) Physiochemical principles of cardiovascular calcification. Z Kardiol 90 Suppl 3:68-80
|
|
Cohen, H; Solomon, V; Alferiev, I S et al. (1998) Bisphosphonates and tetracycline: experimental models for their evaluation in calcium-related disorders. Pharm Res 15:606-13
|
|
Tomazic, B B; Chow, L C; Carey, C M et al. (1997) An in vitro diffusion model for the study of calcification of bovine pericardium tissue. J Pharm Sci 86:1432-8
|
|
Skrtic, D; Eidelman, N; Golomb, G et al. (1996) In vitro inhibition of membrane-mediated calcification by novel phosphonates. Calcif Tissue Int 58:347-54
|
|
Tomazic, B B; Edwards, W D; Schoen, F J (1995) Physicochemical characterization of natural and bioprosthetic heart valve calcific deposits: implications for prevention. Ann Thorac Surg 60:S322-7
|
|
Van Gelder, J M; Breuer, E; Ornoy, A et al. (1995) Anticalcification and antiresorption effects of bisacylphosphonates. Bone 16:511-20
|
|
Tomazic, B B; Brown, W E; Schoen, F J (1994) Physicochemical properties of calcific deposits isolated from porcine bioprosthetic heart valves removed from patients following 2-13 years function. J Biomed Mater Res 28:35-47
|
|
Tomazic, B B; Brown, W E; Eanes, E D (1993) A critical evaluation of the purification of biominerals by hypochlorite treatment. J Biomed Mater Res 27:217-25
|
|
Tomazic, B B; Brown, W E; Queral, L A et al. (1988) Physiochemical characterization of cardiovascular calcified deposits. I. Isolation, purification and instrumental analysis. Atherosclerosis 69:5-19
|
|
Eidelman, N; Chow, L C; Brown, W E (1987) Calcium phosphate phase transformations in serum. Calcif Tissue Int 41:18-26
|
Showing the most recent 10 out of 12 publications
